Vaccinex, Inc. (VCNX): Cash & Equivalents
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$1.11M
As of 2024-12-31
-49.5%
3-year compound annual growth
-16.8%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $1.11M | -27.9% | 2025-04-15, Balance as of period end |
| 2023-12-31 | $1.53M | -76.0% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $6.39M | -25.6% | 2024-04-25, Balance as of period end |
| 2021-12-31 | $8.59M | -18.9% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $10.60M | +281.7% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $2.78M | -50.6% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $5.62M | +34.4% | 2020-03-09, Balance as of period end |
| 2017-12-31 | $4.18M | n/a | 2019-03-13, Balance as of period end |